Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients.
Awni
W M
WM
Hennepin County Medical Center, College of Pharmacy, School of Medicine, University of Minnesota, Minneapolis 55415.
Heim-Duthoy
K
K
Kasiske
B L
BL
D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008074:Lipoproteins / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D011241:Prednisone / Q000008:administration & dosage; D014280:Triglycerides / Q000097:blood
D003524:Cyclosporins; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D014280:Triglycerides; D002784:Cholesterol; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone